Detalhe da pesquisa
1.
ARID1A suppresses R-loop-mediated STING-type I interferon pathway activation of anti-tumor immunity.
Cell
; 2024 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38754421
2.
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer.
N Engl J Med
; 388(23): 2159-2170, 2023 Jun 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36972022
3.
Top advances of the year: Uterine cancer.
Cancer
; 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38620054
4.
Mismatch repair deficiency, next-generation sequencing-based microsatellite instability, and tumor mutational burden as predictive biomarkers for immune checkpoint inhibitor effectiveness in frontline treatment of advanced stage endometrial cancer.
Int J Gynecol Cancer
; 33(4): 504-513, 2023 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36750267
5.
Immunotherapy treatment landscape for patients with endometrial cancer: current evidence and future opportunities.
Clin Adv Hematol Oncol
; 21(1): 27-34, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36638353
6.
KRAS-Mutated, Estrogen Receptor-Positive Low-Grade Serous Ovarian Cancer: Unraveling an Exceptional Response Mystery.
Oncologist
; 26(4): e530-e536, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33528846
7.
PD-1 and PD-L1 Blockade plus Chemotherapy in Endometrial Cancer. Reply.
N Engl J Med
; 389(9): 867-868, 2023 Aug 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37646696
8.
Trends and geographic variation in women's representation as principal investigators (PI) in phase 3 gynecologic oncology clinical trials.
Gynecol Oncol
; 162(2): 389-393, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34099315
9.
Practice patterns and survival in FIGO 2009 stage 3B endometrial cancer.
Gynecol Oncol
; 163(2): 299-304, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34561099
10.
Assessment of malnutrition by unintentional weight loss and its implications on oncologic outcomes in patient with locally advanced cervical cancer receiving primary chemoradiation.
Gynecol Oncol
; 160(3): 721-728, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33342621
11.
Placenta Accreta Spectrum Treatment With Intraoperative Multivessel Embolization: the PASTIME protocol.
Am J Obstet Gynecol
; 225(4): 442.e1-442.e10, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34245679
12.
Unanticipated 30-day readmission following rectosigmoid resection at the time of cytoreductive surgery in patients with advanced stage ovarian cancer.
J Obstet Gynaecol
; 41(6): 956-961, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33228421
13.
Rapid dissemination of practice-changing information: A longitudinal analysis of real-world rates of minimally invasive radical hysterectomy before and after presentation of the LACC trial.
Gynecol Oncol
; 157(2): 494-499, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32081462
14.
Current status of hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian cancer in the United States.
Gynecol Oncol
; 159(3): 681-686, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32977989
15.
Revisiting immunotherapy in endometrial cancer.
Clin Adv Hematol Oncol
; 22(1): 28-30, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38294738
16.
Correlation between Surgeon's assessment and radiographic evaluation of residual disease in women with advanced stage ovarian cancer reported to have undergone optimal surgical cytoreduction: An NRG Oncology/Gynecologic Oncology Group study.
Gynecol Oncol
; 149(3): 525-530, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29550184
17.
Practice changing cervical cancer clinical trials.
Gynecol Oncol
; 165(3): 410-412, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35461731
18.
Expression Patterns of the Wnt Pathway Inhibitors Dickkopf3 and Secreted Frizzled-Related Proteins 1 and 4 in Endometrial Endometrioid Adenocarcinoma: An NRG Oncology/Gynecologic Oncology Group Study.
Int J Gynecol Cancer
; 26(1): 125-32, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26397159
19.
Moving beyond cytotoxic drug dosing in ovarian cancer.
Lancet
; 394(10214): 2043-2045, 2019 12 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31791687
20.
Development of bevacizumab in advanced cervical cancer: pharmacodynamic modeling, survival impact and toxicology.
Future Oncol
; 11(6): 909-22, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25760973